Ivosidenib is an active pharmaceutical ingredient that functions as an inhibitor of isocitrate dehydrogenase 1 (IDH1). It is used in the manufacturing of pharmaceutical products for research and development applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1448347-49-6
Deflazacort
pharmaceutical raw material
Rifamycin O
pharmaceutical raw material
Resiquimod
pharmaceutical raw material
7-oxodehydroepiandrosterone 3-acetate
pharmaceutical raw material
(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxopyrrolidine-2-carboxamide
WIJZXSAJMHAVGX-DHLKQENFSA-N
C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N